Cargando…
Role of the vasodilator peptide angiotensin-(1–7) in cardiovascular drug therapy
The renin-angiotensin-system (RAS) is a cascade of enzymatic reactions resulting ultimately in the formation of angiotensin II. Recent research has expanded the knowledge about the RAS by adding new components to the pathways: angiotensin-(1–5) [Ang-1–5], angiotensin-(1–7) [Ang-(1–7)], angiotensin-(...
Autores principales: | Schindler, Christoph, Bramlage, Peter, Kirch, Wilhelm, Ferrario, Carlos M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1994039/ https://www.ncbi.nlm.nih.gov/pubmed/17583183 |
Ejemplares similares
-
Statin Treatment in Hypercholesterolemic Men Does Not Attenuate Angiotensin II-Induced Venoconstriction
por: Schindler, Christoph, et al.
Publicado: (2014) -
Newer Insights into the Biochemical Physiology of the Renin–Angiotensin System: Role of Angiotensin-(1-7), Angiotensin Converting Enzyme 2, and Angiotensin-(1-12)
por: Ferrario, Carlos M., et al.
Publicado: (2009) -
Regulation of Cardiovascular Control Mechanisms by Angiotensin-(1–7) and Angiotensin-Converting Enzyme 2
por: Ferrario, Carlos M., et al.
Publicado: (2010) -
Angiotensin-(1-7), Angiotensin-Converting Enzyme 2, and New Components of the Renin Angiotensin System
por: Trask, Aaron J., et al.
Publicado: (2009) -
The effect of insulin and enalapril on the potentiation of bradykinin-induced vasodilation by angiotensin-(1–7) in diabetes mellitus
por: Oliveira, MA, et al.
Publicado: (2003)